Loading...

George Yaghmour

Title(s)Assistant Professor of Clinical Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Los Angeles Magazine2017Top Doctors in Southern CA Rising Stars
    Tennessee Oncology Practice Society2015Outstanding Fellow Award
    Asheville Hematologic Malignancies Symposium2015Scholarship Award
    VAMC Memphis2014Star Team Award
    Wayne State University, Henry Ford Hospital 2013Recognized and Ranked Top 5% Internal Medicine Residents
    Henry Ford Hospital2012Outstanding Patient Satisfaction/ Care
    Aleppo University School of Medicine2008Top 1% Graduate Award

    Collapse Overview 
    Collapse Overview
    George Yaghmour, MD has joined the Jane Anne Nohl Division of Hematology as Assistant Professor of Clinical Medicine. Dr. Yaghmour will be working specifically in the areas of Acute Leukemia and Allogeneic Stem Cell Transplantation. He graduated from University of Aleppo, Syria. He performed his residency training in Internal Medicine at Henry Ford Hospital/Wayne State University and then joined University of Tennessee Health Sciences Center/West Cancer Center in Memphis, TN for a clinical fellowship in Hematology and Medical Oncology. He is board certified in Internal Medicine, Hospital Medicine, Hematology and Medical Oncology.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang L, Bargout M, Hon JD, Yaghmour B, Mohrbacher A, Yaghmour G. The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab. World J Oncol. 2020 Feb; 11(1):41-43. PMID: 32095189.
      View in: PubMed
    2. Hagiya A, Vaidya P, Khedro T, Yaghmour B, Siddiqi I, Yaghmour G. Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors. World J Oncol. 2019 Dec; 10(6):226-230. PMID: 31921378.
      View in: PubMed
    3. Vaidya P, Khedro T, Yaghmour B, Yaghmour G. Midostaurin-Related Interstitial Lung Injury in FLT3+ Acute Myeloid Leukemia Post-Allogeneic Transplant. World J Oncol. 2019 Dec; 10(6):237-239. PMID: 31921380.
      View in: PubMed
    4. Martynova A, Nael A, O Neill C, Ramsingh G, Merchant A, Yaghmour B, Yaghmour G. Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant. Br J Haematol. 2019 Sep; 186(5):e139-e141. PMID: 31111479.
      View in: PubMed
    5. Chang J, Douer D, Aldoss I, Vahdani G, Jeong AR, Ghaznavi Z, Zhang S, Yaghmour G, Lee KJ, Weissman A, Akhtari M. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia. Cancer Med. 2019 Jun; 8(6):2832-2839. PMID: 31016870.
      View in: PubMed
    6. McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein MK, Feldman R, Chandler JC, Martin MG. Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2019 01; 173(1):243. PMID: 30306431.
      View in: PubMed
    7. Wang LY, Hu J, Ramsingh G, Theodory B, Yaghmour B, Vergara-Lluri M, Yaghmour G. A Case of Recurrent Pregnancy-Induced Adult Onset Familial Hemophagocytic Lymphohistiocytosis. World J Oncol. 2018 Aug; 9(4):123-127. PMID: 30220951.
      View in: PubMed
    8. Li GX, Wang L, Yaghmour B, Ramsingh G, Yaghmour G. The role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplant. Leuk Res Rep. 2018; 10:26-36. PMID: 30112274.
      View in: PubMed
    9. Ireland C, Wiedower E, Mirza M, Crawley M, Tran A, Yaghmour G, Martin MG. Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma. World J Oncol. 2018 Apr; 9(2):46-49. PMID: 29760832.
      View in: PubMed
    10. Punwani N, Merin N, Mohrbacher A, Yaghmour G, Sano A, Ramezani L, Chaudhary PM, Ramsingh G. Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia. Leuk Res Rep. 2018; 9:18-20. PMID: 29556468.
      View in: PubMed
    11. Igwe IJ, Yang D, Merchant A, Merin N, Yaghmour G, Kelly K, Ramsingh G. The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis. Br J Haematol. 2017 11; 179(4):618-626. PMID: 29047122.
      View in: PubMed
    12. Prouet P, Giri S, Wiedower E, Fintel A, Yaghmour G, Lamb EP, Deneve J, Fleming M, Dickson P, Chandler JC, Martin MG. Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality. Anticancer Res. 2017 02; 37(2):813-817. PMID: 28179335.
      View in: PubMed
    13. Yaghmour G, Wiedower E, Yaghmour B, Nunnery S, Duncavage E, Martin MG. Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine. Ther Adv Hematol. 2017 Feb; 8(2):91-95. PMID: 28203345.
      View in: PubMed
    14. Yaghmour G, Prouet P, Wiedower E, Jamy OH, Feldman R, Chandler JC, Pandey M, Martin MG. Genomic alterations in neuroendocrine cancers of the ovary. J Ovarian Res. 2016 Aug 26; 9(1):52. PMID: 27566252.
      View in: PubMed
    15. Yaghmour G, Pandey M, Ireland C, Patel K, Nunnery S, Powell D, Baum S, Wiedower E, Schwartzberg LS, Martin MG. Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors. Anticancer Res. 2016 Aug; 36(8):4033-8. PMID: 27466509.
      View in: PubMed
    16. McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein K, Feldman R, Chandler JC, Martin MG. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2016 07; 158(1):195-202. PMID: 27329168.
      View in: PubMed
    17. Jamy O, Nunnery S, Giri S, Wiedower E, Johnson B, Yaghmour G, Martin MG. Under-recognition of hemophagocytic syndrome in United States' rural, non-teaching hospitals. Leuk Lymphoma. 2016 12; 57(12):2911-2913. PMID: 27087428.
      View in: PubMed
    18. Johnson B, Giri S, Nunnery SE, Wiedower E, Jamy O, Yaghmour G, Chandler JC, Martin MG. Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome. Clin Lymphoma Myeloma Leuk. 2016 Apr; 16(4):230-6. PMID: 26837475.
      View in: PubMed
    19. Hahn AW, Jamy O, Nunnery S, Yaghmour G, Giri S, Pathak R, Martin MG. How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):646-54. PMID: 26386907.
      View in: PubMed
    20. Jamy O, Yaghmour G, Hare F, Martin MG. Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary. Anticancer Res. 2015 May; 35(5):3091-5. PMID: 25964600.
      View in: PubMed
    21. Hahn A, Giri S, Yaghmour G, Martin MG. Early mortality in acute myeloid leukemia. Leuk Res. 2015 May; 39(5):505-9. PMID: 25726083.
      View in: PubMed
    22. Giri S, Hahn A, Yaghmour G, Martin MG. Ibrutinib has some activity in Richter's syndrome. Blood Cancer J. 2015 Jan 30; 5:e277. PMID: 25635530.
      View in: PubMed
    23. Yaghmour G, Thind R, Kryvenko ON, Ayyad H, Chen A, Kuriakose P. All that glitters is not gold: differential diagnosis of clover-leaf lymphocytes. Int J Hematol. 2013 Jun; 97(6):679-80. PMID: 23625610.
      View in: PubMed
    George's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (91) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (7) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑